Introduction
With the increasing rate on obesity, different surgical procedures started to perform in these patients. Nowadays, bariatric surgery is considered as a reliable and effective method in the treatment of morbid obesity. In this present study, we aimed to investigate whether that was a relationship between the weight loss and age on patients who underwent laparoscopic sleeve gastrectomy (LSG) for morbid obesity.
Materials and Methods
In our clinic, patients who underwent LSG and who
Introduction: Gastrojejunal anastomotic (GJA) ulcers and strictures occur in up to 3-31% and 0.6-16% of patients respectively after laparoscopic Roux-en-Y gastric bypass (LRYGB), and may lead to significant morbidity. The purpose of this study was to evaluate the impact of bioabsorbable staple line reinforcement on the GJA stricture and marginal ulcer rates. We hypothesized that reinforcement would decrease the incidence of marginal ulceration and anastomotic strictures.
Methods: Retrospective
Background: Bariatric care is increasingly being delivered in Canada within publicly funded regional programs. The optimal bariatric surgical procedure for severely obese individuals receiving bariatric care is currently unknown. The objective of this population-based prospective cohort study was to compare the effectiveness of laparoscopic Roux-en-Y gastric bypass (LRYGB), laparoscopic sleeve gastrectomy (LSG), and laparoscopic adjustable gastric banding (LAGB) in severely obese patients.
Meth
Introduction
Type 2 diabetes mellitus (T2DM) comprises 90% of diabetics and is largely the result of excess body weight. There is rising evidence in the literature to suggest that laparoscopic sleeve gastrectomy (LSG) produces effective weight loss and improves obesity-related co-morbidities such as T2DM. The purpose of the study is to observe the effectiveness of LSG in the remission of T2DM.
Methods and Procedures
A retrospective study of 107 diabetic obese patients who underwent LSG at A
Introduction:
Gastrointestinal stromal tumors (GISTs) represent approximately 1% of all GI tumors and are the most frequently diagnosed mesenchymal tumors of the alimentary tract. According to the Surveillance, Epidemiology, and End Result (SEER) cancer data registry, between 1993 and 2002 the incidence of GIST in the United States was 0.32 per 100, 000 people. To compare this to the incidence in the obese population, we performed a retrospective electronic medical records review on all patient